BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23787461)

  • 1. Tailoring the magnetic and pharmacokinetic properties of iron oxide magnetic particle imaging tracers.
    Ferguson RM; Khandhar AP; Arami H; Hua L; Hovorka O; Krishnan KM
    Biomed Tech (Berl); 2013 Dec; 58(6):493-507. PubMed ID: 23787461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo comparison of a tailored magnetic particle imaging blood pool tracer with Resovist.
    Kaul MG; Mummert T; Jung C; Salamon J; Khandhar AP; Ferguson RM; Kemp SJ; Ittrich H; Krishnan KM; Adam G; Knopp T
    Phys Med Biol; 2017 May; 62(9):3454-3469. PubMed ID: 28060771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic particle imaging with tailored iron oxide nanoparticle tracers.
    Ferguson RM; Khandhar AP; Kemp SJ; Arami H; Saritas EU; Croft LR; Konkle J; Goodwill PW; Halkola A; Rahmer J; Borgert J; Conolly SM; Krishnan KM
    IEEE Trans Med Imaging; 2015 May; 34(5):1077-84. PubMed ID: 25438306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic routes to magnetic nanoparticles for MPI.
    Kratz H; Eberbeck D; Wagner S; Taupitz M; Schnorr J
    Biomed Tech (Berl); 2013 Dec; 58(6):509-15. PubMed ID: 23950566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monodisperse magnetite nanoparticle tracers for in vivo magnetic particle imaging.
    Khandhar AP; Ferguson RM; Arami H; Krishnan KM
    Biomaterials; 2013 May; 34(15):3837-45. PubMed ID: 23434348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking short-term biodistribution and long-term clearance of SPIO tracers in magnetic particle imaging.
    Keselman P; Yu EY; Zhou XY; Goodwill PW; Chandrasekharan P; Ferguson RM; Khandhar AP; Kemp SJ; Krishnan KM; Zheng B; Conolly SM
    Phys Med Biol; 2017 May; 62(9):3440-3453. PubMed ID: 28177301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging.
    Starmans LW; Burdinski D; Haex NP; Moonen RP; Strijkers GJ; Nicolay K; Grüll H
    PLoS One; 2013; 8(2):e57335. PubMed ID: 23437371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agents.
    Arami H; Khandhar AP; Tomitaka A; Yu E; Goodwill PW; Conolly SM; Krishnan KM
    Biomaterials; 2015 Jun; 52():251-61. PubMed ID: 25818431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of commercial iron oxide-based MRI contrast agents with synthesized high-performance MPI tracers.
    Lüdtke-Buzug K; Haegele J; Biederer S; Sattel TF; Erbe M; Duschka RL; Barkhausen J; Vogt FM
    Biomed Tech (Berl); 2013 Dec; 58(6):527-33. PubMed ID: 23787462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Particle Imaging Tracers: State-of-the-Art and Future Directions.
    Bauer LM; Situ SF; Griswold MA; Samia AC
    J Phys Chem Lett; 2015 Jul; 6(13):2509-17. PubMed ID: 26266727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long circulating tracer tailored for magnetic particle imaging.
    Liu S; Chiu-Lam A; Rivera-Rodriguez A; DeGroff R; Savliwala S; Sarna N; Rinaldi-Ramos CM
    Nanotheranostics; 2021; 5(3):348-361. PubMed ID: 33850693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic particle imaging: kinetics of the intravascular signal in vivo.
    Haegele J; Duschka RL; Graeser M; Schaecke C; Panagiotopoulos N; Lüdtke-Buzug K; Buzug TM; Barkhausen J; Vogt FM
    Int J Nanomedicine; 2014; 9():4203-9. PubMed ID: 25214784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo liver visualizations with magnetic particle imaging based on the calibration measurement approach.
    Dieckhoff J; Kaul MG; Mummert T; Jung C; Salamon J; Adam G; Knopp T; Ludwig F; Balceris C; Ittrich H
    Phys Med Biol; 2017 May; 62(9):3470-3482. PubMed ID: 28035904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulational validation of color magnetic particle imaging (cMPI).
    Han SH; Cho E; Lee DK; Cho G; Kim YR; Cho H
    Phys Med Biol; 2014 Nov; 59(21):6521-36. PubMed ID: 25309980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic particle imaging: introduction to imaging and hardware realization.
    Buzug TM; Bringout G; Erbe M; Gräfe K; Graeser M; Grüttner M; Halkola A; Sattel TF; Tenner W; Wojtczyk H; Haegele J; Vogt FM; Barkhausen J; Lüdtke-Buzug K
    Z Med Phys; 2012 Dec; 22(4):323-34. PubMed ID: 22909418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance iron oxide nanoparticles for magnetic particle imaging - guided hyperthermia (hMPI).
    Bauer LM; Situ SF; Griswold MA; Samia AC
    Nanoscale; 2016 Jun; 8(24):12162-9. PubMed ID: 27210742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasmall superparamagnetic iron oxide nanoparticles for magnetic resonance imaging contrast agent.
    Zhao X; Zhao H; Chen Z; Lan M
    J Nanosci Nanotechnol; 2014 Jan; 14(1):210-20. PubMed ID: 24730260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low drive field amplitude for improved image resolution in magnetic particle imaging.
    Croft LR; Goodwill PW; Konkle JJ; Arami H; Price DA; Li AX; Saritas EU; Conolly SM
    Med Phys; 2016 Jan; 43(1):424. PubMed ID: 26745935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic Particle Imaging: A Novel in Vivo Imaging Platform for Cancer Detection.
    Yu EY; Bishop M; Zheng B; Ferguson RM; Khandhar AP; Kemp SJ; Krishnan KM; Goodwill PW; Conolly SM
    Nano Lett; 2017 Mar; 17(3):1648-1654. PubMed ID: 28206771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.